GB:0JRU's free cash flow for Q3 2023 was $-4.90M. For the 2023 fiscal year, GB:0JRU's free cash flow was decreased by $-14.07M and operating cash flow was $-4.90M. See a summary of the company’s cash flow.

Cash Flow	TTM	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
Operating Cash Flow	$ -36.49M	$ -60.36M	$ -46.59M	$ -67.47M	$ -134.21M	$ -190.35M
Investing Cash Flow	$ -459.00K	$ 3.65M	$ 12.39M	$ -255.00K	$ -202.00K	$ -4.28M
Financing Cash Flow	-	$ 1.44M	$ 73.62M	$ 41.48M	$ 87.07M	$ 136.40M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	$ 218.05M	$ 64.90M	$ 120.17M	$ 80.75M	$ 107.00M	$ 154.34M
Income Tax Paid Supplemental Data	-	-	$ 40.00K	$ 562.00K	$ 71.00K	$ 377.00K
Interest Paid Supplemental Data	-	-	$ 465.00K	$ 4.01M	$ 6.38M	$ 6.37M
Issuance Of Capital Stock	-	$ 1.44M	$ 89.23M	$ 70.81M	$ 94.55M	$ 134.51M
Issuance Of Debt	-	-	-	-	-	$ 0.00
Repayment Of Debt	-	-	$ -15.73M	$ -29.56M	$ -9.71M	$ 0.00
Free Cash Flow	$ -37.14M	$ -61.05M	$ -46.99M	$ -67.73M	$ -134.41M	$ -194.63M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in USD

Sio Gene Therapies Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing